Explore Prostate Cancer CDX Models:

Model Name	Description
VCaP	Androgen-sensitive prostate cancer model harboring TMPRSS2-ERG gene fusion and wild-type AR; used for studying androgen signaling and anti-androgen therapies.
22RV.1	Castration-resistant prostate cancer (CRPC) model expressing both full-length and splice variant AR-V7; used to evaluate resistance to androgen receptor–targeted therapies.